The Study of the Nonunion of Long Tubular Bone
The Prospective、Randomized、Comparative Clinical Study About the Two Operation Methods Between Anti-rotational Plate Group and Exchanged Intramedullary Nailgroup to Treat the Nonunion of Long Tubular Bone After Intramedullary Nail Fixation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 1
Contacts and Locations
Study Contact
Study Contact
- Name: Bosong BS zhang, MD
- Phone Number: +86 +8613621219567
- Email: zhangbosong@sina.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 730000
- Recruiting
- The orthopaedic Trauma center of Jishuitan Hospital in Beijing
-
Contact:
- xianzhi XZ Ma, MD
- Phone Number: +8615201542942
- Email: 870248900@qq.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patient who had the nonunion of long tubular bone
- The patient who was the age of 14 ~ 65 years old.
- The patient who complete the follow-up conditions.
- The patient who has independent behavior ability.
- The patient who volunteered for signed informed consent
Exclusion Criteria:
- Infectious nonunion of the long turubar bone
- Pathological fracture.
- The immune system disease.
- Cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: The Anti-rotational plate group
The method was used to control the rotational unstabilization at the fracture site
|
|
|
Placebo Comparator: Exchanged Intramedullary nailing group
the method Provided the axial and rotational stability
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The healing rate
Time Frame: 9 months
|
9 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Bosong Zhang, MD, Jishuitan hospital in Beijing
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Z141107002514086
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.